Medtronic received information that during the attempted implant of this 25mm bioprosthetic valve, it was replaced with a 23mm valve of the same model.The reason for the replacement was reported as after the valve was sutured, it was found that the valve could not be placed smoothly and could not be inserted smoothly in the patient's aortic valve due to the suture ring of the valve being too large.It was reported that the valves corresponding sizers were used for this implant and the barrel end of the sizer was used.It was also reported that the replica end of the sizer was used as well as a reference for the valve implant size.It was stated that "according to conventional valve measurement", the 25mm valve was selected.It was noted that preoperative comparison was performed normally and no root expansion was performed.A body surface area (bsa) chart was also used, and the patient was found to be within the reasonable range.It is unknown whether the annulus was felt to be between two different valve sizes.Pledgets were not used.It was also reported that there were no unique patient anatomical factors that contributed to not being able to implant the valve identified with the sizer.It was indicated that the physician had experience implanting 10 of these valves prior to this procedure.No additional adverse patient effects were reported.
|
Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|